Literature DB >> 18227395

Genotype and vascular phenotype linked by catecholamine systems.

David S Goldstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18227395      PMCID： PMC5253708          DOI： 10.1161/CIRCULATIONAHA.107.745737

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  33 in total

1.  BETA-HYDROXYLATED SYMPATHOMIMETIC AMINES AS FALSE NEUROTRANSMITTERS.

Authors:  J E FISCHER; W D HORST; I J KOPIN
Journal:  Br J Pharmacol Chemother       Date:  1965-04

2.  [Differences between tyramine and dimethylphenylpiperazine in the Ca++-dependency and in the temporary course of noradrenaline release from the isolated rabbit heart].

Authors:  R Lindmar; K Löffelholz; E Muscholl
Journal:  Experientia       Date:  1967-11-15

3.  Vascular responsiveness to norepinephrine in sympathicotonic orthostatic intolerance.

Authors:  J W Miller; D H Streeten
Journal:  J Lab Clin Med       Date:  1990-05

4.  Metabolic fate of the sympathoneural imaging agent 6-[18F]fluorodopamine in humans.

Authors:  D S Goldstein; C Holmes
Journal:  Clin Exp Hypertens       Date:  1997 Jan-Feb       Impact factor: 1.749

5.  Cardiac uptake-1 inhibition by high circulating norepinephrine levels in patients with pheochromocytoma.

Authors:  Basil A Eldadah; Karel Pacak; Graeme Eisenhofer; Courtney Holmes; Irwin J Kopin; David S Goldstein
Journal:  Hypertension       Date:  2004-04-12       Impact factor: 10.190

6.  Uptake and efflux of noradrenaline from platelets; a model system for neurogenic mechanisms in essential hypertension.

Authors:  I Mattiasson; B Mattiasson; B Hood
Journal:  Clin Sci (Lond)       Date:  1979-12       Impact factor: 6.124

7.  The broader view: catecholamine abnormalities.

Authors:  Simi Vincent; David Robertson
Journal:  Clin Auton Res       Date:  2002-05       Impact factor: 4.435

8.  Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue.

Authors:  T Kurz; G Richardt; M Seyfarth; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

9.  The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline.

Authors:  A Langeloh; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

10.  Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo.

Authors:  Fangwen Rao; Lian Zhang; Jennifer Wessel; Kuixing Zhang; Gen Wen; Brian P Kennedy; Brinda K Rana; Madhusudan Das; Juan L Rodriguez-Flores; Douglas W Smith; Peter E Cadman; Rany M Salem; Sushil K Mahata; Nicholas J Schork; Laurent Taupenot; Michael G Ziegler; Daniel T O'Connor
Journal:  Circulation       Date:  2007-08-13       Impact factor: 29.690
View more
  2 in total

1.  The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors.

Authors:  Vincent Van den Eynde
Journal:  J Neural Transm (Vienna)       Date:  2021-08-09       Impact factor: 3.575

2.  Perivascular adipose tissue contains functional catecholamines.

Authors:  N Ayala-Lopez; M Martini; W F Jackson; E Darios; R Burnett; B Seitz; G D Fink; S W Watts
Journal:  Pharmacol Res Perspect       Date:  2014-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.